Patent · US Active

Uracil derivatives as AXL and c-MET kinase inhibitors

US9029538B2 · kind B2 · utility

7Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 13, 2014
Grant dateMay 12, 2015
Priority date—
Expiry dateMay 13, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/056
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides compounds of Formula Ior salt forms thereof, wherein Ra, Rb, Rc, Rd, D, W, R1a, R1b, R1c, Y, R3, X, E and G are as defined herein, compositions, methods of treatment and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.